Dipeptidyl peptidase IV inhibitor lowers PPARγ agonist-induced body weight gain by affecting food intake, fat mass, and beige/brown fat but not fluid retention.
American journal of physiology. Endocrinology and metabolism Feb, 2014 | Pubmed ID: 24347054